FDA Drug Topics: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update - April 26, 2021
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Monday, April 26, 2021, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update. This webinar discussed how the Office of Orphan Products Development (OOPD) advances the development of products for rare diseases. The webinar also reviewed the history of OOPD, the Orphan Drug Act, and other core programs within OOPD.
View Presentation Here: https://collaboration.fda.gov/poawxlt4tsxq/
Download Presentation Slides: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update (PDF - 1.95MB)
Activity Outline and Continuing Education Information: FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update (PDF - 167KB)
If you have never attended an Adobe Connect meeting before (Google Chrome (preferred) or Firefox 43 or higher):
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Resources For You